• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ABC 1183

CAS No. 1042735-18-1

ABC 1183 ( ABC1183 )

产品货号. M10214 CAS No. 1042735-18-1

ABC1183 是一种有效、选择性、口服活性的 GSK3α/β 和 CDK9 抑制剂,IC50 分别为 327/657 nM 和 321 nM (CDK9/cyclin T1)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥478 有现货
10MG ¥786 有现货
25MG ¥1604 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    ABC 1183
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    ABC1183 是一种有效、选择性、口服活性的 GSK3α/β 和 CDK9 抑制剂,IC50 分别为 327/657 nM 和 321 nM (CDK9/cyclin T1)。
  • 产品描述
    ABC1183 is a potent, selective, orally active GSK3α/β and CDK9 inhibitor with IC50 of 327/657 nM and 321 nM (CDK9/cyclin T1), shows growth inhibitory activity against a broad panel of cancer cell lines; decreases cell survival through G2/M arrest and modulates oncogenic signaling through changes in GSK3, GS and β-catenin phosphorylation and MCL1 expression; suppresses tumor growth and inflammation-driven gastrointestinal disease symptoms without organ or hematological toxicity in vivo.
  • 体外实验
    ABC1183 (3 μM, 24 h) can block cell cycle progression and thus affect cell proliferation. Cell Cycle Analysis Cell Line:LNCaP human prostate cancer cells Concentration:3 μM Incubation Time:24 hours Result:Significantly reduced cells in the G1 and S phases and increased cells in the G2/M and sub-G1 cycle phases.
  • 体内实验
    ABC1183 (oral gavage, 5 or 50 mg/kg) inhibits tumor proliferation through negative regulation of cell growth and pro-inflammatory signalling in male C57BL/6 mice. Animal Model:Male C57BL/6 mice with melanoma B16 Dosage:5 mg/kg Administration:Oral gavage; 5 times per week; 22 days Result:Reduced tumor size and no observed toxicity.Decreased the expression levels of GSK3 α /β, pSer21/9 and GS pSer641 but no change of total GS expression.Animal Model:Male C57BL/6 mice infected crohn’s disease Dosage:50 mg/kg Administration:Oral gavage; everyday; 3 days Result:Reduced TNF-α by 65%, IL-6 by 30% and IL-1β by 45%.Animal Model:Male C57BL/6 mice with ulcerative colitisDosage:50 mg/kg Administration:Oral gavage; once daily; 6 days Result:Increased the expression of the anti-inflammatory factor IL-10, while decreasing the pro-inflammatory factor IL-6.
  • 同义词
    ABC1183
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    GSK-3
  • 受体
    GSK-3
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1042735-18-1
  • 分子量
    334.397
  • 分子式
    C18H14N4OS
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 125 mg/mL (373.82 mM)
  • SMILES
    N#CC1=CC=C(C(C2=C(N)N=C(NC3=CC=C(C)C=C3)S2)=O)C=C1
  • 化学全称
    4-(4-Amino-2-p-tolylamino-thiazole-5-carbonyl)-benzonitrile

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Schrecengost RS, et al. J Pharmacol Exp Ther. 2018 Feb 6. pii: jpet.117.245738.
产品手册
关联产品
  • GSK3β inhibitor II

    GSK3β inhibitor II 是 GSK3β 的抑制剂。GSK3β inhibitor II 可用于阿尔茨海默病 (AD) 的研究。

  • 5-Bromoindole

    5-溴吲哚是一种潜在的糖原合酶激酶3(GSK-3)抑制剂,也是一种重要的医药化工中间体。

  • CCG 203769

    CCG 203769 是 RGS4 的选择性抑制剂,对于 RGS4-Gαo 蛋白质-蛋白质相互作用的 IC50 为 17 nM。